
Sign up to save your podcasts
Or
Dr Benjamin Levy from Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial in Washington, DC, discusses important efficacy and safety data from 2024 related to the use of approved and investigational therapies for localized and advanced non-small cell lung cancer without a targetable mutation.
CME information and select publications here.
4.9
5656 ratings
Dr Benjamin Levy from Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial in Washington, DC, discusses important efficacy and safety data from 2024 related to the use of approved and investigational therapies for localized and advanced non-small cell lung cancer without a targetable mutation.
CME information and select publications here.
138 Listeners
17 Listeners
30 Listeners
13 Listeners
71 Listeners
13 Listeners
76 Listeners
0 Listeners
321 Listeners
116 Listeners
500 Listeners
57 Listeners
3,332 Listeners
200 Listeners
44 Listeners
21 Listeners
366 Listeners
185 Listeners
43 Listeners
0 Listeners